Glaxosmithkline Company Profile
✉ Email this page to a colleague
Biologic Drugs for Glaxosmithkline
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 10,537,580 | 2035-03-19 | Patent claims search |
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 9,115,113 | 2033-11-14 | Patent claims search |
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 9,169,212 | 2034-01-16 | Patent claims search |
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 9,339,510 | 2034-01-16 | Patent claims search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.